vs

Side-by-side financial comparison of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) and Verisign (VRSN). Click either name above to swap in a different company.

Verisign is the larger business by last-quarter revenue ($425.3M vs $220.8M, roughly 1.9× UNIVERSAL TECHNICAL INSTITUTE INC). Verisign runs the higher net margin — 48.5% vs 5.8%, a 42.7% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 5.2%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

UTI vs VRSN — Head-to-Head

Bigger by revenue
VRSN
VRSN
1.9× larger
VRSN
$425.3M
$220.8M
UTI
Growing faster (revenue YoY)
UTI
UTI
+2.1% gap
UTI
9.6%
7.6%
VRSN
Higher net margin
VRSN
VRSN
42.7% more per $
VRSN
48.5%
5.8%
UTI
More free cash flow
VRSN
VRSN
$304.3M more FCF
VRSN
$285.1M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
5.2%
VRSN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
UTI
UTI
VRSN
VRSN
Revenue
$220.8M
$425.3M
Net Profit
$12.8M
$206.2M
Gross Margin
88.5%
Operating Margin
7.1%
67.0%
Net Margin
5.8%
48.5%
Revenue YoY
9.6%
7.6%
Net Profit YoY
-42.1%
7.7%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UTI
UTI
VRSN
VRSN
Q4 25
$220.8M
$425.3M
Q3 25
$222.4M
$419.1M
Q2 25
$204.3M
$409.9M
Q1 25
$207.4M
$402.3M
Q4 24
$201.4M
$395.4M
Q3 24
$196.4M
$390.6M
Q2 24
$177.5M
$387.1M
Q1 24
$184.2M
$384.3M
Net Profit
UTI
UTI
VRSN
VRSN
Q4 25
$12.8M
$206.2M
Q3 25
$18.8M
$212.8M
Q2 25
$10.7M
$207.4M
Q1 25
$11.4M
$199.3M
Q4 24
$22.2M
$191.5M
Q3 24
$18.8M
$201.3M
Q2 24
$5.0M
$198.8M
Q1 24
$7.8M
$194.1M
Gross Margin
UTI
UTI
VRSN
VRSN
Q4 25
88.5%
Q3 25
88.4%
Q2 25
88.0%
Q1 25
87.7%
Q4 24
87.8%
Q3 24
88.0%
Q2 24
87.8%
Q1 24
87.2%
Operating Margin
UTI
UTI
VRSN
VRSN
Q4 25
7.1%
67.0%
Q3 25
11.2%
67.8%
Q2 25
6.9%
68.5%
Q1 25
8.1%
67.4%
Q4 24
13.6%
66.7%
Q3 24
13.3%
68.9%
Q2 24
4.2%
68.8%
Q1 24
6.1%
67.4%
Net Margin
UTI
UTI
VRSN
VRSN
Q4 25
5.8%
48.5%
Q3 25
8.4%
50.8%
Q2 25
5.2%
50.6%
Q1 25
5.5%
49.5%
Q4 24
11.0%
48.4%
Q3 24
9.6%
51.5%
Q2 24
2.8%
51.4%
Q1 24
4.2%
50.5%
EPS (diluted)
UTI
UTI
VRSN
VRSN
Q4 25
$0.23
Q3 25
$0.33
Q2 25
$0.19
Q1 25
$0.21
Q4 24
$0.40
Q3 24
$0.35
Q2 24
$0.09
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UTI
UTI
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$162.8M
$580.5M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$335.9M
$-2.2B
Total Assets
$834.0M
$1.3B
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UTI
UTI
VRSN
VRSN
Q4 25
$162.8M
$580.5M
Q3 25
$169.1M
$617.7M
Q2 25
$70.7M
$593.8M
Q1 25
$96.0M
$648.5M
Q4 24
$172.0M
$599.9M
Q3 24
$161.9M
$644.9M
Q2 24
$115.5M
$689.9M
Q1 24
$116.1M
$924.7M
Total Debt
UTI
UTI
VRSN
VRSN
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
UTI
UTI
VRSN
VRSN
Q4 25
$335.9M
$-2.2B
Q3 25
$328.1M
$-2.1B
Q2 25
$306.8M
$-2.0B
Q1 25
$293.9M
$-2.0B
Q4 24
$280.0M
$-2.0B
Q3 24
$260.2M
$-1.9B
Q2 24
$239.4M
$-1.8B
Q1 24
$232.6M
$-1.6B
Total Assets
UTI
UTI
VRSN
VRSN
Q4 25
$834.0M
$1.3B
Q3 25
$826.1M
$1.4B
Q2 25
$740.8M
$1.4B
Q1 25
$720.4M
$1.4B
Q4 24
$753.8M
$1.4B
Q3 24
$744.6M
$1.5B
Q2 24
$706.0M
$1.5B
Q1 24
$702.1M
$1.7B
Debt / Equity
UTI
UTI
VRSN
VRSN
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UTI
UTI
VRSN
VRSN
Operating Cash FlowLast quarter
$3.1M
$289.6M
Free Cash FlowOCF − Capex
$-19.2M
$285.1M
FCF MarginFCF / Revenue
-8.7%
67.0%
Capex IntensityCapex / Revenue
10.1%
1.1%
Cash ConversionOCF / Net Profit
0.24×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$16.6M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UTI
UTI
VRSN
VRSN
Q4 25
$3.1M
$289.6M
Q3 25
$57.1M
$307.7M
Q2 25
$18.1M
$202.5M
Q1 25
$-789.0K
$291.3M
Q4 24
$23.0M
$231.5M
Q3 24
$67.5M
$253.4M
Q2 24
$10.0M
$160.4M
Q1 24
$-2.5M
$257.3M
Free Cash Flow
UTI
UTI
VRSN
VRSN
Q4 25
$-19.2M
$285.1M
Q3 25
$40.6M
$303.0M
Q2 25
$6.8M
$194.7M
Q1 25
$-11.7M
$285.5M
Q4 24
$19.6M
$222.0M
Q3 24
$60.0M
$247.8M
Q2 24
$3.0M
$151.2M
Q1 24
$-8.4M
$253.5M
FCF Margin
UTI
UTI
VRSN
VRSN
Q4 25
-8.7%
67.0%
Q3 25
18.3%
72.3%
Q2 25
3.4%
47.5%
Q1 25
-5.7%
71.0%
Q4 24
9.7%
56.1%
Q3 24
30.6%
63.4%
Q2 24
1.7%
39.1%
Q1 24
-4.6%
66.0%
Capex Intensity
UTI
UTI
VRSN
VRSN
Q4 25
10.1%
1.1%
Q3 25
7.4%
1.1%
Q2 25
5.5%
1.9%
Q1 25
5.3%
1.4%
Q4 24
1.7%
2.4%
Q3 24
3.8%
1.4%
Q2 24
4.0%
2.4%
Q1 24
3.2%
1.0%
Cash Conversion
UTI
UTI
VRSN
VRSN
Q4 25
0.24×
1.40×
Q3 25
3.04×
1.45×
Q2 25
1.69×
0.98×
Q1 25
-0.07×
1.46×
Q4 24
1.04×
1.21×
Q3 24
3.58×
1.26×
Q2 24
2.01×
0.81×
Q1 24
-0.32×
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

VRSN
VRSN

Segment breakdown not available.

Related Comparisons